Insulin Pump Cybersecurity Patents: Who Leads, White Space 2026
Insulin pump cybersecurity patents: who holds the pairing architecture, and where the claim space is still open
Filings are accelerating again after dropping to zero at the 2022 midpoint, following a 2020 peak of 6 annual filings. Annual filings rose from 3 in 2017 to a peak of 6 in 2020, dropped to 0 at the 2022 midpoint, and the trend since has been climbing again — 2026 figures are partial because of publication lag, so the true current-year total is understated.
- 1DEXCOM INC39
- 2ROCHE DIABETES CARE INC5
- 3F HOFFMANN LA ROCHE & CO AG4
- 4ROCHE DIABETES CARE GMBH2
- 5INSULET CORP2
See the full insulin pump cybersecurity analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Insulin pump cybersecurity patents: what practitioners ask
Who holds the most influential insulin pump cybersecurity patents?
The most-cited record in this dataset is US9980140B1, a secure communication architecture for medical devices credited to Insulet Corporation, followed closely by its own continuation US10341866B1. A separate but heavily cited cluster covers integrated insulin-delivery systems paired with continuous glucose sensors. Citation count favours older filings, so treat this as a map of influence within the searched corpus rather than a claim that these are the newest or most commercially dominant patents today.
What patent classes cover insulin pump cybersecurity?
This landscape is defined by the intersection of A61M5/172 (insulin delivery devices), H04L9 (cryptographic techniques for digital transmission) and G16H40 (healthcare informatics for device management). In practice, G16H and A61M carry the bulk of the 53 records, while H04L, H04W and G06K — the network and pattern-recognition layers — are comparatively thin. That split tells you claim activity has focused more on the device-and-data-management layer than on the radio or recognition layers.
Is the insulin pump cybersecurity patent field still growing?
Filings rose from 3 in 2017 to a peak of 6 in 2020, dipped to 0 at the 2022 midpoint, and the underlying trend since has turned upward again. Because publication typically lags filing by around 18 months, the most recent year in any dataset like this one is always undercounted, so the actual 2025–2026 filing rate is likely higher than currently visible. Read the recent uptick as accelerating interest rather than a plateau.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Insulin Pump Cybersecurity covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.